XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
2 Months Ended 7 Months Ended 9 Months Ended
Sep. 30, 2023
Jul. 31, 2023
Jul. 21, 2023
Sep. 30, 2022
Adjustments to reconcile net loss to net cash used in operating activities:        
Change in fair value of convertible notes     $ 19,359 $ (15,261)
Change in fair value of warrants $ (1,593)      
Change in fair value of embedded forward purchase agreements and derivative liabilities 15,776   11,789  
Change in fair value of contingent consideration (75,939)      
Predecessor [Member]        
Cash flows from operating activities:        
Net (loss) income   $ (60,678)   (17,993)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation   54   36
Write-off of deferred offering costs       331
Stock-based compensation expense   3,235   4,224
Change in fair value of convertible notes   19,359   (15,261)
Change in fair value of embedded forward purchase agreements and derivative liabilities   11,789    
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets   36   (15)
Accounts payable   (248)   1,433
Accrued expenses and other liabilities   4,736   284
Other assets and liabilities   (28)   (169)
Net cash used in operating activities   (21,745)   (27,130)
Cash flows from investing activities:        
Purchases of property and equipment       (297)
Net cash used in investing activities       (297)
Cash flows from financing activities:        
Proceeds from issuance of convertible notes   14,000   44,500
Net cash provided by financing activities   14,000   44,500
Net (decrease) increase in cash   (7,745)   17,073
Cash at beginning of period   9,746 9,746 5,128
Cash at end of period   $ 2,001   $ 22,201
Successor [Member]        
Cash flows from operating activities:        
Net (loss) income 50,289      
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 21      
Stock-based compensation expense 2,171      
Change in fair value of warrants (1,593)      
Change in fair value of embedded forward purchase agreements and derivative liabilities 15,776      
Change in fair value of contingent consideration (75,939)      
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets (363)      
Accounts payable (3,716)      
Accrued expenses and other liabilities (1,701)      
Other assets and liabilities (6)      
Net cash used in operating activities (15,061)      
Cash flows from financing activities:        
Net (decrease) increase in cash (15,061)      
Cash at end of period $ 16,177   $ 31,238